DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
ADX-71149 is an investigational drug.
There have been 12 clinical trials for ADX-71149. The most recent clinical trial was a Phase 3 trial, which was initiated on November 15th 2019.
The most common disease conditions in clinical trials are Sleepiness, Narcolepsy, and Disorders of Excessive Somnolence. The leading clinical trial sponsors are Aldeyra Therapeutics, Inc., Jazz Pharmaceuticals, and Q32 Bio Inc.
There are two US patents protecting this investigational drug and forty international patents.
Recent Clinical Trials for ADX-71149
|A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis||Aldeyra Therapeutics, Inc.||Phase 2|
|A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.||Aldeyra Therapeutics, Inc.||Phase 2|
|A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)||Aldeyra Therapeutics, Inc.||Phase 2|
Top disease conditions for ADX-71149
Top clinical trial sponsors for ADX-71149
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|ADX-71149||⤷ Sign up for a Free Trial||1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4'] bipyridinyl-2'-ones||Janssen Pharmaceuticals, Inc. (Titusville, NJ) Addex Pharma SA (Geneva, CH)||⤷ Sign up for a Free Trial|
|ADX-71149||⤷ Sign up for a Free Trial||1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2- '-ones||Janssen Pharmaceuticals, Inc. (Titusville, NJ) Addex Pharma SA (Geneva, CH)||⤷ Sign up for a Free Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|ADX-71149||Argentina||AR068511||2027-09-14||⤷ Sign up for a Free Trial|
|ADX-71149||Austria||AT496906||2027-09-14||⤷ Sign up for a Free Trial|
|ADX-71149||Australia||AU2008297878||2027-09-14||⤷ Sign up for a Free Trial|
|ADX-71149||Brazil||BRPI0816767||2027-09-14||⤷ Sign up for a Free Trial|
|ADX-71149||Canada||CA2696948||2027-09-14||⤷ Sign up for a Free Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|